Cardiology in the Young · 2002 · 34 citations · 8 references
MedicineCardiologyInternal MedicineClinical CardiologyMolecular DiagnosticsPathophysiologyCardiac BiomarkersCardiac PhysiologyCardiovascular DiseaseElectrocardiogram AnalysisElectrocardiogram InterpretationElectrocardiographyBiochemical Marker AssaysBiochemical Marker AssessmentBiomarkers Of MyocarditisConcentrationElectrocardiogram DiagnosisElectrocardiographic BiomarkersQrs Complex Detection
UNLABELLED: So as to determine the value of brain natriuretic peptide in the plasma as a biochemical marker for myocarditis of Kawasaki disease, we studied 69 patients. The blood samples, electrocardiograms and cross-sectional echocardiograms were obtained before the commencement of treatment and in the convalescent phase. RESULTS: The mean concentration of brain natriuretic peptide in the plasma was 73.2 +/- 107.7 (mean +/- SD) pg/ml in the acute phase, and 7.9 +/- 7.5 pg/ml in the convalescent phase. We checked the electrocardiograms to find abnormal Q waves, elevation or depression of the ST segments, change in the pattern of the QRS complexes, and flattening or inversion of the T wave, all believed to be markers of myocarditis in Kawasaki disease. Those in whom the concentrations were greater than 50 pg/ml in the acute phase showed abnormal electrocardiograms more frequently than did those in whom the values were less than 50 pg/ml (21/29 vs 3/40, p < 0.0001 odds ratio 32.4). Amplitudes of the T wave in standard limb leads were measured both in the acute and convalescent phases, and the differences calculated. We regarded the sum total of these differences as representing "flattening T wave", and we named this variable as the total suppressed T wave voltage. We examined the correlation between the variable and the levels of brain natriuretic peptide in the plasma during the acute phase, demonstrating a significant correlation (r = 0.500, p < 0.0001). We conclude, therefore, that the concentration of brain natriuretic peptide measured in the plasma can be a useful biochemical marker for the myocarditis of Kawasaki disease. When the titer is over 50 pg/ml, the patient probably has an abnormal electrocardiogram and is most likely to have myocarditis.
8
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
Guillermo Torre‐Amione, Samir Kapadia, Joseph Lee et al. · Circulation · 1996 · 995 citations
Medicine, Cardiology, Immunology +11
Pathology of the Heart in Kawasaki Disease
Hisayoshi Fujiwara, Yoshihiro Hamashima · PEDIATRICS · 1978 · 554 citations
Medicine, Cardiology, Pathology +17
Cardiac biopsy of Kawasaki disease.
Chikao Yutani, S. E. Go, Tadashi Kamiya et al. · PubMed · 1981 · 183 citations
Medicine, Cardiology, Pathology +16